Update on Proposed Acquisition Strategy
Filed with ASX · · 1 page · English
Sydney Australia, 24 March 2026: Genetic Technologies Limited (ASX: GTG, “Company”, “GTG”) advises that it will no longer be proceeding with the previously contemplated acquisition of Ellerfield Wealth and Walker Capital Private Wealth now known as Ellerfield Private Wealth. Following further strategic review, the Board has determined that it is in the best interests of shareholders to discontinue
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Long Term Suspended Entities
- Quarterly Activities/Appendix 4C Cash Flow Report
- FY25 Appendix 4D and Half Year Accounts
- Binding Term Sheets Executed
- Update on Board and Executive Changes
Later from Genetic Technologies
- Quarterly Activities/Appendix 4C Cash Flow Report March 2025
- Quarterly Activities/Appendix 4C Cash Flow Report June 2025
- Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025
- Suspension from Official Quotation - Annual Listing Fees
- FY25 Appendix 4E & Annual Report
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies